Munafa Stock Market Course + Intraday & FNO calls 
RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE
Dr. Reddy's Laboratories Ltd Complete list of announcements declared & dividend announcements by Dr. Reddy's Laboratories Ltd RDY
Dr. Reddy's Laboratories Ltd RDY listed on NYSE and deals in Health Care Major PharmaceuticalsAnnouncements and dividends declared by Dr. Reddy's Laboratories Ltd RDY
Dr Reddy's Laboratories Q3 Results: Profit falls 14% YoY to Rs 1,210 crore, revenue up 4%
Dr Reddy’s Laboratories reported a 14% YoY drop in Q3 net profit to Rs 1,210 crore, even as revenue rose 4% to Rs 8,727 crore. Lower margins and a 12% decline in North America sales weighed on performance, partly offset by strong growth in India, Europe an
Announcement as on 21 January 2026
Dr Reddy's Q3 preview: PAT may fall 22% YoY as US pressure to weigh on earnings
Dr Reddy's Laboratories anticipates a subdued performance for the December quarter. Pressure from its United States business is expected to offset steady growth in India and Europe. Analysts predict a decline in revenue and profit after tax. The US market
Announcement as on 20 January 2026
Dr Reddy’s inks licensing deal to sell Immutep’s cancer drug
Dr. Reddy's Laboratories has secured an exclusive licensing agreement with Immutep to manufacture, develop, and distribute the Australian company's cancer therapy, eftilagimod alfa. This significant deal, valued at up to 0 million, grants Dr. Reddy's di
Announcement as on 08 December 2025
India weight-loss market reset? In setback for Novo Nordisk, Dr Reddy's Lab allowed to make semaglutide
The order follows the court’s view that Novo Nordisk’s patent appears prima facie invalid -- a finding that could reshape competitive dynamics in a market valued at around Rs 850 crore.
Announcement as on 03 December 2025
HC lets Dr Reddy's Laboratories export Semaglutide, blocks India sales till March '26
The Delhi High Court has permitted Dr Reddy's Laboratories to produce and export its version of the diabetes and anti-obesity drug semaglutide. This decision comes amidst a patent infringement case filed by Novo Nordisk. Dr Reddy's is restricted from selli
Announcement as on 03 December 2025
Announcements by Dr. Reddy's Laboratories Ltd first page | Next page | Prev page |
RDY Dr. Reddy's Laboratories Ltd current price & indicator signals
Recent prices of RDY Dr. Reddy's Laboratories Ltd are as follows: Daily volume is divided by 10 day averaged volume
| Date | Close | Range | Change % | Volume |
| 28 Fri Aug 2026 | 12.18 | 12.12 to 12.33 | 0.16% | 0.75 times |
| 27 Thu Aug 2026 | 12.16 | 12.13 to 12.24 | -0.49% | 0.7 times |
| 26 Wed Aug 2026 | 12.22 | 12.14 to 12.30 | -0.97% | 0.75 times |
| 25 Tue Aug 2026 | 12.34 | 12.22 to 12.38 | 0.98% | 0.79 times |
| 24 Mon Aug 2026 | 12.22 | 12.13 to 12.25 | 0.33% | 0.93 times |
| 21 Fri Aug 2026 | 12.18 | 12.07 to 12.23 | 0.58% | 0.91 times |
| 20 Thu Aug 2026 | 12.11 | 12.05 to 12.23 | 0% | 1.15 times |
| 19 Wed Aug 2026 | 12.11 | 11.99 to 12.22 | -0.33% | 1.46 times |
| 18 Tue Aug 2026 | 12.15 | 12.06 to 12.21 | 0.33% | 1.38 times |
| 17 Mon Aug 2026 | 12.11 | 12.06 to 12.24 | -1.3% | 0.92 times |
| 14 Fri Aug 2026 | 12.27 | 12.22 to 12.39 | -1.21% | 1.02 times |
| 13 Thu Aug 2026 | 12.42 | 12.37 to 12.51 | 0.24% | 1.26 times |
Videos related to: RDY announcements Dr. Reddy's Laboratories Ltd announcements and dividends declared NYSE
Hindi Video Correct Way Of Fundamental Analysis Using EPS And PE - MunafaSutra
Hindi Video What Is Needed To Succeed In Stock Markets
- NYSE Screeners
- NYSE Daily Screener
- NYSE Weekly Screener
- NYSE Monthly Screener
- Support & Resistance
- NYSE Shares Near Support
- NYSE Shares Near Resistance
